ClavystBio β Full Portfolio
24 tracked investments Β· listed companies and verified rows first
Eyexora is a pharmaceutical company focused on ophthalmology and eye care treatments, serving patients and healthcare providers in the therapeutic and biologics space.
BiotechHealthtechMedical DevicesSingapore, SG
Theresa Heah(CEO, Vice-Chair and Co-Founder)Welyn Bui(President and Chief Operating Officer)in
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsF-Prime CapitalGV (Google Ventures)Bluebird VenturesCasdin CapitalEuropean Innovation Council FundEuropean Investment Bank+6 more
65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.
BiotechDeep TechSingapore, SG
BoardSteve Courtney(Expert in Residence)
Co-investorsLightstone VenturesLeaps by Bayer
Allay Therapeutics develops localized pain management technology designed to deliver several weeks of post-surgical pain relief.
BiotechHealthtechMedical DevicesSan Jose, US
Adam Gridley(Executive Officer, Director)inKristen Howells(Executive Officer)inJosh Makower(Director)Tak Cheung(Director)inKarun D. Naga(Executive Officer, Director)
BoardLeighton Read(Director)
Co-investorsArboretum VenturesLightstone VenturesNew Enterprise Associates (NEA)SGInnovate
Automera develops an autophagy-powered small molecule degrader platform designed to accelerate drug development and reduce costs in therapeutic creation.
AI & Machine LearningBiotechDeep Tech
Zian-Loong Wang(Chief Technology Officer & Co-Founder)Michael Lazarou(Co-Founder)inThong Q. Le(Chief Executive Officer)in
Co-investorsACCELERATOR LIFE SCIENCE PARTNERSXora Innovation Pte Ltd
Droia Ventures is a specialist venture capital firm investing globally in early-stage drug development companies focused on therapeutics for oncology and genetic disease.
BiotechLeuven, BE
Co-investorsFrazier Life SciencesLifeArc VenturesNovo Holdings
Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.
AI & Machine LearningBiotechDeep TechHealthtech
Piers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)Dipti Thakkar(Chief Operating Officer)in
Co-investorsAltium CapitalDecheng CapitalDroia VenturesFrazier Life SciencesKiwoom InvestmentMuirwoods Ventures+5 more
NSG Bio operates BSL-2 certified co-working wet-laboratory and office spaces for life sciences and biotech companies in Singapore, offering turnkey facilities, shared equipment, and support services for startups and multinationals conducting R&D.
BiotechPropTechSingapore, SG
Daphne Teo(Founder)in
Co-investorsNSG Ventures
Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.
BiotechDigital HealthHealthtechMedical DevicesSingapore, SG
Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in
Co-investorsAngelini VenturesKurma PartnersBoehringer Ingelheim Venture FundHighlight CapitalSEEDS Capital
Paratus Sciences is a drug discovery company that uses AI-powered methods to identify first-in-class medicines by studying evolutionary traits, targeting serious diseases where current therapies are inadequate.
AI & Machine LearningBiotechDeep TechUnited States, US
Co-investorsARCH Venture PartnersEcoR1 CapitalLeaps by Bayer
Polaris Partners is an investment firm with nearly 30 years of experience backing healthcare and biotech companies, focusing on innovative care delivery, digital health, consumer-centric businesses, therapeutics, and genomics.
BiotechDigital HealthHealthtech
Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.
BiotechFemTechHealthtechMedical DevicesBedford, US
AMARPREET SAWHNEY(Executive Officer, Director, Promoter)inAmar Sawhney(Founder)inNICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)
BoardTARA BUTLER(Executive Officer, Director, Promoter)
Co-investorsAscension VenturesDelos CapitalFemHealth VenturesIyengar Capital PartnersAmed VenturesCatalyst Health Ventures
Biotechnology company developing blood-based diagnostic tests for neurological disorders and early-stage cancer.
Cambridge, US
Co-investorsARCH Venture PartnersPolaris Partners
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Accelerator Life Science Partners (ALSP)Callio TherapeuticsCirrus TherapeuticsCoVBioDroiaEngine BiosciencesLightstone VenturesMediSix TherapeuticsQuiltRemiges VenturesRespiree
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.